Leo Pharma absorbs scrapped innovation hubs to streamline focus
![Leo Pharma's head of research and development, Jörg Möller, will still have to keep track of three development hubs across the US and Asia, despite the organization at large refocusing its internal R&D | Photo: MAGNUS MØLLER](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article13917670.ece/ALTERNATES/schema-16_9/doc7kj3zczgp8hhm32wayd.jpg)
Leo Pharma previously reported that its three external innovations hubs were to close, but this isn’t entirely the case. Going forward, the units will become part of Leo Pharma’s internal research organization, according to Jörg Möller, head of global research and development at Leo Pharma.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Small molecules to lead Leo Pharma to greatness
For subscribers
Leo Pharma ends Boston bet
For subscribers
Leo Pharma's Boston boss exits company
For subscribers